2017 Resolution on international cooperation to address and counter the world drug problem
Analysis of precedential value
This resolution was adopted by the UN General Assembly (UNGA) without a general vote in February 2017. The UNGA is the preeminent governing body of the UN system and consists of all 193 UN Member States.
The draft of this resolution was co-authored by 11 UN Member States and co-sponsored by 30 others. It was approved by the UNGA Social, Humanitarian and Cultural Committee before being presented to the entire body.
Used as precedent
gender equality
“Reiterates its call to mainstream a gender perspective into and ensure the involvement of women in all stages of the development, implementation, monitoring and evaluation of drug policies and programmes, to develop and disseminate gender-sensitive and age-appropriate measures that take into account the specific needs and circumstances faced by women and girls with regard to the world drug problem and, as States parties, implement the Convention on the Elimination of All Forms of Discrimination against Women.” (paragraph 14)
combination prevention, harm reduction
“Urges Member States to increase the availability, coverage and quality of scientific evidence-based prevention measures and tools that target relevant age and risk groups in multiple settings, reaching youth in school as well as out of school, among others, through drug abuse prevention programmes and public awareness-raising campaigns, including by using the Internet, social media and other online platforms, to develop and implement prevention curricula and early intervention programmes for use in the education system at all levels, as well as in vocational training, including in the workplace, and to enhance the capacity of teachers and other relevant professionals to provide or recommend counselling, prevention and care services.” (paragraph 15)
combination prevention
“Invites Member States to consider enhancing cooperation among public health, education and law enforcement authorities when developing prevention initiatives.” (paragraph 16)
harm reduction
“Encourages Member States to promote the inclusion in national drug policies, in accordance with national legislation and as appropriate, of elements for the prevention and treatment of drug overdose, in particular opioid overdose, including the use of opioid receptor antagonists, such as naloxone, to reduce drug-related mortality.” (paragraph 19)
“Calls upon Member States to enhance access to treatment for drug use disorders for those who are incarcerated and promote effective oversight and encourage, as appropriate, self-assessments of confinement facilities, taking into consideration the United Nations standards and norms on crime prevention and criminal justice, including the United Nations Standard Minimum Rules for the Treatment of Prisoners (the Nelson Mandela Rules), implement, where appropriate, measures aimed at addressing and eliminating prison overcrowding and violence, and provide capacity-building to relevant national authorities.” (paragraph 30)
“Encourages Member States to ensure that measures to prevent the illicit cultivation of and to eradicate plants containing narcotic and psychotropic substances respect fundamental human rights, take due account of traditional licit uses, where there is historical evidence of such use, and of the protection of the environment, in accordance with the three international drug control conventions, and also take into account, as appropriate and in accordance wi th national legislation, the United Nations Declaration on the Rights of Indigenous Peoples.” (paragraph 63)
combination prevention, negative legal determinants
“Encourages the development, adoption and implementation, with due regard for national, constitutional, legal and administrative systems, of alternative or additional measures with regard to conviction or punishment in cases of an appropriate nature, in accordance with the three international drug control conventions and taking into account, as appropriate, relevant United Nations standards and rules, such as the United Nations Standard Minimum Rules for Non-custodial Measures (the Tokyo Rules).” (paragraph 24)
harm reduction, human rights
“Emphasizes the need to enhance the knowledge of policymakers and the capacity, as appropriate, of relevant national authorities on various aspects of the world drug problem in order to ensure that national drug policies, as part of a comprehensive, integrated and balanced approach, fully respect all human rights and fundamental freedoms and protect the health, safety and well-being of individuals, families, vulnerable members of society, communities and society as a whole, and to that end encourages the cooperation of Member States with, and cooperation among, the United Nations Office on Drugs and Crime, the International Narcotics Control Board, the World Health Organization and other relevant United Nations entities, within their respective mandates, including those relevant to the above-mentioned issues, and relevant regional and international organizations, as well as with civil society and the private sector, as appropriate.” (paragraph 27)
stigma and discrimination
“Urges Member States to ensure non-discriminatory access to health, care and social services in prevention, primary care and treatment programmes, including those offered to persons in prison or pretrial detention, which are to be on a level equal to those available in the community, and to ensure that women, including detained women, have access to adequate health services and counselling, including those particularly needed during pregnancy.” (paragraph 28)
human rights, positive legal determinants
“Encourages the promotion, where appropriate, in the framework of international cooperation, of the use of law enforcement techniques, consistent with national legislation and international law, including applicable human rights obligations, in order to ensure that drug traffickers are brought to justice and that major criminal organizations are disrupted and dismantled.” (paragraph 38)
access to health products, harm reduction
“Urges all Member States to enact comprehensive measures aimed at stemming the abuse of prescription drugs, in particular through the establishment of awareness-raising initiatives targeting the general public and health-care providers.” (paragraph 45)
“Calls upon Member States to continue efforts to identify and monitor trends in the composition, production, prevalence and distribution of new psychoactive substances, as well as patterns of use and adverse consequences, and assess the risks to the health and safety of individuals and society as a whole and the potential uses of new psychoactive substances for medical and scientific purposes, and on that basis to develop and strengthen domestic and national legislative, regulatory, administrative and operational responses and practices by domestic and national legislative, law enforcement, judiciary, social and welfare, educational and health authorities.” (paragraph 55)
access to health products
“Invites Member States to target the illicit cultivation of crops used for the illicit production and manufacture of drugs and address related factors by implementing comprehensive strategies aimed at alleviating poverty and strengthening the rule of law, accountable, effective and inclusive institutions and public services and institutional frameworks, as appropriate, and by promoting sustainable development aimed at enhancing the welfare of the affected and vulnerable population through licit alternatives.” (paragraph 56)